Entrada Therapeutics (TRDA) Tax Rate (2023 - 2026)

Entrada Therapeutics (TRDA) posted quarterly Tax Rate of 0.1% for Q1 2026, up 62.58% quarter-over-quarter from 0.26% in Q4 2025.

Entrada Therapeutics (TRDA) Tax Rate (2023 - 2026) Analysis & Trends

Entrada Therapeutics' Tax Rate history runs 4 years deep, the most recent figure standing at 0.1% for Q1 2026.

In Q1 2026, Tax Rate changed N/A year-over-year to 0.1%; the TTM figure through Mar 2026 stood at 0.6% (up 331.0% YoY), while the FY2025 annual figure was 0.63%, down 192.0% from the prior year.
Tax Rate for Q1 2026 stood at 0.1%, up from 0.26% in the prior quarter.
The five-year high for Tax Rate was 253.04% in Q4 2024, with the low at 114.62% in Q2 2023.
The 4-year median for Tax Rate is 0.18% (2026), against an average of 12.76%.
The sharpest annual moves came in 2024 and 2025: Tax Rate surged 12093 bps in 2024, then sank 25330 bps in 2025.
Entrada Therapeutics' Tax Rate stood at 203.33% in 2023, then increased by 24 bps to 253.04% in 2024, then tumbled by 100 bps to 0.26% in 2025, then surged by 63 bps to 0.1% in 2026.
Business Quant data shows TRDA's Tax Rate at 0.1% in Q1 2026, 0.26% in Q4 2025, and 1.5% in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Entrada Therapeutics	290.47 Mn	290.47 Mn	-	-0.08%

Download Data